Unlike ERK, the other mitogen-activated protein kinase (MAPK); p38 MAPK and c-jun terminal kinase (JNK), and nuclear factor-κB (NFκB) pathways have not been frequently linked to melanoma incidences [1]. This evidence concerns the gene WNK2 and melanoma.